Diversity of phage infection types and associated terminology: the problem with ‘Lytic or lysogenic’

FEMS Microbiology Letters

Volumn 363, Issue 7, 2016, Pages

  Hobbs, Zack ^a   Abedon, Stephen T ^b  

^a EpiBiome Inc ^*  (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

lytic phage; obligately lytic; phage therapy; professionally lytic; strictly lytic; temperate phage

Indexed keywords

BACTERIOPHAGE; BACTERIUM CONTAMINATION; BIOLOGICAL PEST CONTROL; LYSIS; LYSOGENIZATION; MICROBIAL COMMUNITY; NOMENCLATURE; NONHUMAN; PHAGE THERAPY; REVIEW; VIRUS RELEASE; BACTERIOLYSIS; BACTERIUM; CLASSIFICATION; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

BACTERIA; BACTERIOLYSIS; BACTERIOPHAGES; LYSOGENY; PHAGE THERAPY; TERMINOLOGY AS TOPIC;

EID: 85011742534     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1093/FEMSLE/FNW047     Document Type: Review

References (52)

1. Abedon ST. The murky origin of Snow White and her T-even dwarfs. Genetics 2000;155:481–6.
2. Abedon ST. Phages, ecology, evolution. In: Abedon ST (ed.). Bacteriophage Ecology. Cambridge, UK: Cambridge University Press, 2008, 1–28.
3. Abedon ST. Disambiguating bacteriophage pseudolysogeny: an historical analysis of lysogeny, pseudolysogeny, and the phage carrier state. In: Adams HT (ed.). Contemporary Trends in Bacteriophage Research. Hauppauge. New York: Nova Science Publishers, 2009. 285–307.
4. Abedon ST. Phage therapy of pulmonary infections. Bacteriophage 2015;5:e1020260-1–e1020260-13.
5. Abedon ST, Duffy S, Turner PE. Bacteriophage ecology. In: Schaecter M (ed.). Encyclopedia of Microbiology. Oxford: Elsevier, 2009, 42–57.
6. Abedon ST, Kuhl SJ, Blasdel BG et al. Phage treatment of human infections. Bacteriophage 2011;1:66–85.
7. Adams MH. Bacteriophages. New York: InterScience, 1959.
8. Bourdin G, Navarro A, Sarker SA et al. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails. Microb Biotechnol 2014;7:165–76.
9. Brüssow H. Phage therapy: the Escherichia coli experience. Microbiology 2005;151:2133–40.
10. Brüssow H. Phage therapy: the Western perspective. In: Mc Grath S, van Sinderen D (eds). Bacteriophage: Genetics and Microbiology. Norfolk, UK: Caister Academic Press, 2007, 159–92.
11. Brüssow H, Kutter E. Genomics and the evolution of tailed phages. In: Kutter E, Sulakvelidze A (eds). Bacteriophages: Biology and Application. Boca Raton, Florida: CRC Press, 2005, 91–128.
12. Calendar R, Abedon ST. The Bacteriophages, 2nd edn. Oxford: Oxford University Press, 2006.
13. Casjens SR, Hendrix RW. Bacteriophage lambda: early pioneer and still relevant. Virology 2015;479–480:310–30.
14. Christie GE, Allison HA, Kuzio J et al. Prophage-induced changes in cellular cytochemistry and virulence. In: Hyman P, Abedon ST (eds). Bacteriophages in Health and Disease. Wallingford, UK: CABI Press, 2012, 33–60.
15. Curtright AJ, Abedon ST. Phage therapy: emergent property pharmacology. J Bioanalyt Biomed 2011;S3:010.
16. Fane BA, Brentlinger KL, Burch AD et al. The Microviridae. In: Calendar R, Abedon ST (eds). The Bacteriophages, 2nd edn. Oxford: Oxford University Press, 2006, 129–45.
17. Fogg PC, Allison HE, Saunders JR et al. Bacteriophage lambda: a paradigm revisited. J Virol 2010;84:6876–9.
18. Górski A, Miedzybrodzki R, Borysowski J et al. Bacteriophage therapy for the treatment of infections. Curr Opin Investig D 2009;10:766–74.
19. Hendrix RW, Roberts JW, Stahl FW et al. Lambda II. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1983.
20. Henein A. What are the limitations on the wider therapeutic use of phage? Bacteriophage 2013;3:e24872.
21. Hershey AD, Dove W. Introduction to Lambda. In: Hendrix RW, Roberts JW, Stahl FW, Weisberg RA (eds). Lambda II. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1983, 3–11.
22. Hyman P, Abedon ST. Phage ecology of bacterial pathogenesis. In: Abedon ST (ed.). Bacteriophage Ecology. Cambridge, UK: Cambridge University Press, 2008, 353–85.
23. Hyman P, Abedon ST. Bacteriophage host range and bacterial resistance. Adv Appl Microbiol 2010;70:217–48.
24. Hyman P, Abedon ST. Smaller fleas: viruses of microorganisms. Scientifica 2012;2012:734023.
25. Karam JD. Molecular Biology of Bacteriophage T4. Washington, DC: ASM Press, 1994.
26. Krupovic M, Forterre P. Microviridae goes temperate: microvirusrelated proviruses reside in the genomes of Bacteroidetes. PLoS One 2011;6:e19893.
27. Kuhl S, Hyman P, Abedon ST. Diseases caused by phages. In: Hyman P, Abedon ST (eds). Bacteriophages in Health and Disease. Wallingford, UK: CABI Press, 2012, 21–32.
28. Kutter E. Phage therapy: bacteriophages as naturally occurring antimicrobials. In: Goldman E, Green LH (eds). Practical Handbook of Microbiology. Boca Raton, FL: CRC Press, 2008, 713–30.
29. Kutter E, De Vos D, Gvasalia G et al. Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechno 2010;11:69–86.
30. Kutter EM, Gvasalia G, Alavidze Z et al. Phage therapy. In: Grassberger M, Sherman RA, Gileva O, Kim C, Mumcuoglu KY (eds). Biotherapy - History, Principles and Practice. New York: Springer, 2013, 191–231.
31. Letarov A, Kulikov E. The bacteriophages in human- and animal body-associated microbial communities. J Appl Microbiol 2009;107:1–13.
32. Letarov AV, Golomidova AK, Tarasyan KK. Ecological basis of rational phage therapy. Acta Naturae 2010;2:60–71.
33. Los M, Wegrzyn G. Pseudolysogeny. Adv Virus Res 2012;82:339–49.
34. Lwoff A. Lysogeny. Bacteriol Rev 1953;17:269–337.
35. Lwoff A. The prophage and I. In: Cairns J, Stent GS, Watson JD (eds). Phage and the Origins of Molecular Biology (expanded edition). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1966, 88–99.
36. Mai-Prochnow A, Hui JG, Kjelleberg S et al. Big things in small packages: the genetics of filamentous phage and effects on fitness of their host. FEMS Microbiol Rev 2015;39: 465–87.
37. Maniloff J, Dybvig K. Mycoplasma phages. In: Calendar R, Abedon ST (eds). The Bacteriophages. Oxford: Oxford University Press, 2006.
38. Maniloff J, Kampo GJ, Dascher CC. Sequence analysis of a unique temperature phage: mycoplasma virus L2. Gene 1994;141:1–8.
39. Miller ES, Kutter E, Mosig G et al. Bacteriophage T4 genome. Microbiol Mol Biol R 2003;67:86–156.
40. Miller RV, Day M. Contribution of lysogeny, pseudolysogeny, and starvation to phage ecology. In: Abedon ST (ed.). Bacteriophage Ecology. Cambridge, UK: Cambridge University Press, 2008, 114–43.
41. Mindich L. Phages with segmented double-stranded RNA genomes. In: Calendar R, Abedon ST (eds). The Bacteriophages, 2nd edn. Oxford: Oxford University Press, 2006, 197–207.
42. Miroshnikov KA, Kulikov EE, Darbeeva OS et al. Genetic and molecular principles for the selection of Pseudomonas and Staphylococcus therapeutic bacteriophages. Appl Biochem Micro 2014;50:306–12.
43. Ptashne M. Genetic Switch: Phage Lambda Revisited. 3rd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, 2004.
44. Russel M, Model P. Filamentous bacteriophages. In: Calendar R, Abedon ST (eds). The Bacteriophages, 2nd edn. Oxford: Oxford University Press, 2006, 146–60.
45. Sarker SA, McCallin S, Barretto C et al. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology 2012;434:222–32.
46. Smith HW, Huggins MB, Shaw KM. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 1987;133:1111–26.
47. Stent GS. Molecular Biology of Bacterial Viruses. San Francisco, CA: WH Freeman and Co., 1963.
48. Summers WC. From culture as organisms to organisms as cell: historical origins of bacterial genetics. J Hist Biol 1991;24: 171–90.
49. van Duin J, Tsareva N. Single-stranded RNA phages. In: Calendar R, Abedon ST (eds). The Bacteriophages, 2nd edn. Oxford: Oxford University Press, 2006, 175–96.
50. Weiss M, Denou E, Bruttin A et al. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Virology 2009;393:16–23.
51. Yamada T, Kawasaki T, Nagata S et al. New bacteriophages that infect the phytopathogen Ralstonia solanacearum. Microbiology 2007;153:2630–9.
52. Young R. Phage lysis: three steps, three choices, one outcome. J Microbiol 2014;52:243–58.